Dorsey Wright & Associates’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
RSCM
CAM
OMC
Dorsey Wright & Associates's LKFT Position: Q3 2020 in Review
Dorsey Wright & Associates sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 34,082 shares — an estimated $6.82M sold.
Dorsey Wright & Associates first reported a position in LKFT in Q2 2017 and held it in 13 quarters. The position peaked at $9.31M in Q2 2018. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.
- Dorsey Wright & Associates reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
- Dorsey Wright & Associates sold 34,082 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $6.82M.
- Dorsey Wright & Associates first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 13 quarters.
- Dorsey Wright & Associates's Lakefront Biotherapeutics American Depositary Shares position peaked at $9.31M in Q2 2018.
- 119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.
Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.